跳至主要内容
临床试验/ITMCTR2200006866
ITMCTR2200006866尚未招募未知

Clinical trial on prevention as well as reduction of chemotherapy-induced neuropathy with acupuncture treatment on the breast cancer patients

Jiangsu Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
Female

入选标准

  • (1) Patients with histological diagnosis of stage I-III breast cancer, excluding distant metastases
  • (2) Patients who plan to receive adjuvant or neoadjuvant chemotherapy (with or without HER-2 targeted therapy) must be enrolled before the second adjuvant chemotherapy.
  • (3) Over 18 years of age
  • (4) Sign informed consent
  • 6. No serious organic damage to heart, kidney, liver or brain;
  • 7. Signed the informed consent, participated in and randomly assigned to a study group with no history of substance abuse, and actively cooperated with treatment and follow-up.

排除标准

  • (1) Previous CIPN-causing chemotherapy (one dose of chemotherapy allowed).
  • (2) There were unstable heart disease and myocardial infarction in the first six months
  • (3) Have a pacemaker or implantable cardioverter defibrillator
  • (4) Uncontrollable seizures
  • (5) Prior peripheral neuropathy (PRO-CTCAE CIPN Scale)
  • (6) Acupuncture within three months before enrollment

研究者

发起方
Jiangsu Provincial Hospital of Traditional Chinese Medicine

相似试验